Dec 2, 2005 (CIDRAP News) – A test to screen blood and organ donors for West Nile virus (WNV) has won approval by the Food and Drug Administration (FDA) after 2 years of trial use.The FDA yesterday announced approval of the Procleix West Nile virus assay, developed by Gen-Probe Inc., San Diego, and marketed by Chiron Corp., Emeryville, Calif. The test detects West Nile RNA in blood.The test has been used to screen more than 29 million units of donated blood since June 2003 and has detected the virus in more than 1,500 cases, preventing transfusion of contaminated blood into as many as 4,500 people, Gen-Probe officials said in a news release.The test is intended to help protect recipients of donated blood and organs from the virus. The FDA said there have been 30 cases in which people probably acquired WNV from a blood transfusion, and nine of the patients died.”This approval is the result of a tremendous cooperative effort among FDA, other public health agencies, the test kit manufacturers and the blood industry,” Jesse Goodman, MD, MPH, director of the FDA’s Center for Biologics Evaluation and Research, said in a news release.”To develop an investigational test to screen blood, tissue and organ donors, and to get this test in blood banks throughout the country, and then licensed this quickly is a remarkable achievement for public health and patient safety,” Goodman added.Another blood test is available to help doctors diagnose WNV, but it must be used in tandem with other laboratory tests, according to a Reuters report published yesterday. Procleix is the first approved test that stands alone, making it suitable for use by blood banks, the story said.Another WNV blood test, developed by Roche Molecular Systems, Inc., is still being used experimentally, Reuters reported. An FDA official said the agency is allowing Roche to use the test on a trial basis until it has enough data to apply for approval, the story said.Efforts to develop a WNV blood test began in 2002 when it was discovered that the virus could be transmitted in blood, the FDA said. With help from the FDA and other federal health agencies, biotechnology firms developed investigational tests that were quickly adopted on a trial basis. A total of about 1,600 infected donations were detected by the investigational tests, the FDA said.Close to 20,000 cases of WNV illness, with 762 deaths, have occurred in the United States since the virus first arrived in 1999, the FDA said.See also:FDA news release about WNV blood testhttp://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/2005/ucm108523.htmApr 8, 2004, CIDRAP News story “Six West Nile cases in 2003 linked to donated blood”
Tipp FM’s live coverage of this Sundays National Hurling League quarter final is in association with Donal Ryan Motor Group Nenagh, Thurles & Roscrea and Racket Hall Country House Hotel, Roscrea. Throw in is at 4pm in O’Connor Park. Michael Ryans men make the short trip to Tullamore to take on Offaly in a game which many pundits say is a foregone conclusion.Offaly made the knockout stages of the competition despite winning just one of their league matches.Despite this Tipp manager Michael Ryan says they won’t be taking them for granted.
World Bank Country Director for Haiti, Anabela Abreu, said “the downturn in the economy caused by the spread of COVID-19 will pose a setback for poverty reduction and inclusive growth in Haiti. Ongoing projects have provided rapid financing for priorities such as food security under the Haiti Resilient Productive Landscape Project, and social protection using cash transfers under the Municipal Development and Urban Resilience Project, the World Bank said. The Washington-based financial institution said the funds from its International Development Association (IDA) aims to increase Haiti’s capacity to mitigate the impacts of the COVID-19 outbreak and enhance resilience to natural hazards and health-related shocks. The World Bank noted that the government of Haiti has declared a state of emergency since March 19, announcing early actions including containment measures and a social protection program to mitigate the impact on poor and vulnerable households. “This operation supports key policy reforms to reduce the negative economic and social impacts on the most vulnerable. A stronger institutional framework will also increase resilience to future disasters, which is particularly important given the country’s high exposure to hurricanes and other natural hazards,’ she added. WASHINGTON – The World Bank has approved a US$20 million grant for the Haiti COVID-19 Response and Resilience Development Policy Operation. The Haiti COVID-19 Response and Resilience Development Policy Operation supports health emergency preparedness and response capacity and the strengthening of the social protection system for improved emergency cash transfer programmes. The financial institution said the challenges are further compounded with the approaching hurricane season “as Haiti remains highly vulnerable to natural hazards.” CMC The World Bank said additional actions include the operationalization of the National Disaster Risk Management System (SNGRD) and the new Civil Protection General Directorate (DGPC), together with the development of a National Disaster Risk Financing Strategy. It said this operation is part of a broader package of support from the international financial institution that includes the US$20 million Haiti COVID-19 Response Project, focused on efforts in the health sector to limit the transmission of COVID-19 through detection and infection control.